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ABSTRACT Lys-553 of skeletal muscle myosin subfragment 1 (S1) was specifically labeled with the fluorescent probe FHS
(6-[fluorescein-5(and 6)-carboxamido]hexanoic acid succinimidyl ester) and fluorescence quenching experiments were car-
ried out to determine the accessibility of this probe at Lys-553 in both the strongly and weakly actin-bound states of the
MgATPase cycle. Solvent quenchers of varying charge [nitromethane, (2,2,6,6-tetramethyl-1-piperinyloxy) (TEMPO), iodide
(I), and thallium (Tl)] were used to assess both the steric and electrostatic accessibilities of the FHS probe at Lys-553. In
the strongly bound rigor (nucleotide-free) and MgADP states, actin offered no protection from solvent quenching of FHS by
nitromethane, TEMPO, or thallium, but did decrease the Stern-Volmer constant by almost a factor of two when iodide was
used as the quencher. The protection from iodide quenching was almost fully reversed with the addition of 150 mM KCl,
suggesting this effect is ionic in nature rather than steric. Conversely, actin offered no protection from iodide quenching at
low ionic strength during steady-state ATP hydrolysis, even with a significant fraction of the myosin heads bound to actin.
Thus, the lower 50 kD subdomain of myosin containing Lys-553 appears to interact differently with actin in the weakly and
strongly bound states.
INTRODUCTION
At the molecular level muscle contraction is driven by the
cyclic interaction of two filamentous proteins, myosin and
actin. The globular portion of myosin (subfragment 1 or S1)
is an enzyme that utilizes the hydrolysis of ATP to provide
both the chemical energy needed for muscle contraction and
a means of mediating the affinity between actin and myosin
during the contractile cycle. In the absence of ATP myosin
binds tightly to actin in a rigor complex, but rapidly disso-
ciates from the thin filament upon binding ATP. After the
hydrolysis of ATP to form ADP and inorganic phosphate
(Pi), myosin can rebind to actin in a rapid-equilibrium,
weakly bound state. Release of Pi is thought to result in a
large conformational change in myosin in which the mole-
cule increases its affinity for actin by several orders of
magnitude and goes through a “powerstroke” to generate
force and/or motion within the muscle fiber. Thus the re-
sulting myosin  ADP state, like the rigor state, remains
tightly bound to actin until the next ATPase cycle is initi-
ated by the binding of a new molecule of ATP.
The atomic structures of myosin S1 (Rayment et al.,
1993a; Dominguez et al., 1998; Houdusse et al., 1999) and
the actin monomer (Kabsch et al., 1990) have provided
valuable insights as to how the hydrolysis of ATP and
subsequent product release may give rise to the conforma-
tional changes in myosin required to bind tightly to actin
and generate force and/or myofilament sliding. Specifically,
conformational changes at the active site are thought to be
propagated both back to the long -helical neck of the
myosin molecule, which acts as a mechanical lever arm
during the powerstroke, and to the front of the molecule
containing the actin-binding interface. The putative actin-
binding interface is split by a large cleft, the opening and
closing of which may be responsible for mediating the
affinity by actin and myosin (Rayment et al., 1993b). At-
tempts have been made to further define the actin-binding
interface of myosin by using three-dimensional reconstruc-
tions of cryoelectron micrographs of myosin subfragment 1
(S1) bound to F-actin to “dock” the atomic structures of S1
and actin together in a rigor complex (Rayment et al.,
1993b; Milligan, 1996; Mendelson and Morris, 1997). The
resulting models postulate that myosin binds to actin in a
sequential, multi-step process, in which myosin first binds
to actin in a weakly bound, rapid equilibrium state, followed
by the formation of a strongly bound, stereospecific com-
plex. The weakly bound state is believed to involve a
primarily ionic interaction between the positively charged,
flexible surface loop that links the 50 kD and 20 kD tryptic
fragments of the myosin heavy chain and the negatively
charged N-terminus of actin. The strongly bound state is
thought to involve at least two major structural subdomains
within myosin, a helix-loop-helix motif located in the lower
half of the 50 kD tryptic subdomain of the myosin heavy
chain, and a surface loop that extends out from the upper
half of the 50 kD tryptic subdomain of the myosin heavy
chain. The lower 50 kD subdomain of myosin is thought to
bind to actin first and involve both ionic and stereospecific
hydrophobic components, followed by stereospecific com-
ponents from the upper 50 kD subdomain. However, most
of the specific interactions between actin and myosin pro-
posed in this model are speculative, and require experimen-
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tal verification or refutation for the molecular details of the
acto-myosin interface to be completely understood.
Of the three putative actin-binding subdomains within
myosin, the flexible loop at the 50/20 kD junction is the best
studied and characterized. There is extensive literature dem-
onstrating that this site is protected from proteolytic cleav-
age by actin (Mornet et al., 1979), and that alterations in this
loop have an impact upon the actin-activated ATPase and
actin-binding activities of myosin (Uyeda et al., 1994;
Rovner et al., 1995). The roles of the upper and lower 50 kD
subdomains of myosin S1 within the actin-binding interface
are less clear, with virtually no experimental evidence in-
dicating the upper 50 kD subdomain is involved with actin
binding at all. Indirect evidence that the lower 50 kD
subdomain of myosin forms an important part of the acto-
myosin interface has been obtained by Onishi et al. (1995),
who demonstrated that mutating two hydrophobic amino
acids in this region to more polar residues (W546S and
F547H) results in greatly depressed actin-activated ATPase
activities. Furthermore, Bertrand et al. (1995) have shown
that Lys-553 of myosin S1 could be specifically labeled
with the fluorescent probe FHS (6-[fluorescein-5(and 6)-
carboxamidohexanoic acid succinimidyl ester) and that this
reaction could be blocked when myosin was bound to actin
in a rigor complex.
To more directly examine the role of the helix-loop-helix
motif in the lower 50 kD subdomain of skeletal muscle
myosin S1 in forming the tightly bound complex with actin,
we have labeled Lys-553 with FHS as described by Ber-
trand et al. (1995). Lys-553 is in the middle of the second of
the two helices (residues Asp-547 to His-558) in this puta-
tive interface region of myosin and has been postulated to
bind directly to actin (Rayment et al., 1993b; Milligan,
1996; Mendelson and Morris, 1997). In the current study we
have used solvent quenchers that vary in charge (nitrometh-
ane, TEMPO, thallium chloride, and potassium iodide) to
directly probe the accessibility and electrostatic environ-
ment around Lys-553 of myosin when bound to actin in
both the strongly (i.e., rigor (nucleotide-free) and in the
presence of MgADP) and weakly (i.e., during steady-state
ATP hydrolysis) bound states of the MgATPase cycle.
METHODS
Chemicals and solutions
FHS was purchased from Molecular Probes (Eugene, OR). TEMPO
(2,2,6,6-tetramethyl-1-piperinyloxy), nitromethane, potassium iodide, and
thallium acetate were all purchased from Aldrich (Milwaukee, WI). ATP,
ADP, and all other reagents (at least analytical grade and of the highest
purity possible) were purchased from Sigma (St. Louis, MO).
Proteins
Papain myosin subfragment 1 (S1) was prepared from rabbit skeletal
muscle as described previously (Margossian and Lowey, 1982) and labeled
at Lys-553 with FHS by the method of Bertrand et al. (1995). Concentra-
tions of unmodified S1 were determined spectrophotometrically at 280 nm
using an extinction coefficient of 0.75 (mg/ml)1 cm1. Concentrations of
FHS-modified S1 were determined in an identical manner after correcting
the absorbance at 280 nm for contribution of the dye (  2.04  104 M1
cm1). FHS concentrations were determined spectrophotometrically at 495
nm using an extinction coefficient of 68  104 M1 cm1. Rabbit skeletal
F-actin was prepared by the method of Pardee and Spudich (1982), and
concentrations of G-actin were determined spectrophotometrically at 290
nm using an extinction coefficient of 0.63 (mg/ml)1 cm1. Protein purity
was assessed using SDS-polyacrylamide gel electrophoresis by the method
of Laemmli (1970). Limited tryptic digestion (trypsin/S1 ratio of 1:100
wt/wt for 10 min at 25°C) was carried out on samples of FHS-S1 to ensure
that the 50 kD subdomain containing Lys-553 was selectively labeled.
Tryptic digests were subsequently analyzed by SDS-polyacrylamide gel
electrophoresis and visualized for fluorescence on a UV light box.
Actin-activated ATPase and actin
cosedimentation assays
Actin-activated ATPase assays were performed at 25°C in 10 mM MOPS,
5 mM MgATP, 3 mM MgCl2, 25 mM EGTA, pH 7.1; 0.05–0.10 mg/ml of
S1 or FHS-S1 was assayed with 0–80 M F-actin, and the rate of
phosphate production measured colorimetrically by the method of Lanzetta
et al. (1979). Rates of ATP hydrolysis were plotted versus actin concen-
tration and fit to Michaelis-Menten kinetics using a nonlinear least-squares
routine in SigmaPlot (v5.0, SPSS Inc., Chicago, IL).
Actin cosedimentation assays were performed by incubating 1–2 M S1
or FHS-S1 with varying concentrations of actin under rigor conditions (10
mM MOPS, 8 mM MgCl2, 25 mM EGTA, pH 7.1 at 25°C) for 30 min.
Some experiments, as noted in the text, also included 2 mM MgADP or 20
mM MgATP. F-actin concentrations varied from 5 to 10 M for the rigor
and MgADP experiments to 10–80 M for the MgATP experiments.
Samples were then centrifuged for 30 min at 95,000 rpm in a Beckman
TL-100 tabletop ultracentrifuge using a TLA 120.2 rotor. The resulting
supernatant was removed, and the pellet was washed with 10 mM MOPS,
pH 7.1 and resuspended in SDS-PAGE sample buffer in a volume equal to
that of the supernatant. In addition to samples of the supernatant and pellet,
equal amounts of the sample taken before centrifugation were subjected to
SDS-PAGE. Assay results were assessed by visual inspection of Coomas-
sie stained gels, comparing the amounts of S1 or FHS-S1 present in the
supernatant and pellet relative to the amount present before centrifugation.
The NH4
/Ca2 ATPase activity of the resulting supernatants was also
determined and compared with a zero-actin control to determine the
amount of S1 or FHS-S1 bound to actin in the pellet (Chalovich and
Eisenberg, 1982; Berger et al., 1989).
Fluorescence spectroscopy
Fluorescence emission spectra were collected with a Quantamaster flu-
orometer (Photon Technology International, South Brunswick, NJ). Sam-
ples of FHS-S1 were excited by a 75 W xenon arc lamp through a
single-grating monochromator at 470 nm. The emitted fluorescence was
collected from 500 to 600 nm using a single-grating monochromator
interfaced to a PMT and computer for data storage and analysis. Slit widths
were 2 nm.
Solvent-quenching experiments were performed with 1 M FHS-S1 in
the absence or presence of varying concentrations of F-actin at 25°C in 10
mM MOPS, 8 mM MgCl2, and 25 mM EGTA, pH 7.1. Some experiments,
as noted in the text, also included 2 mM ADP or 20 mM MgATP, and/or
150 mM KCl. F-actin concentrations varied from 5 to 10 M for the rigor
and MgADP experiments to 10–80 M for the MgATP experiments.
Fluorescence values were taken at the peak of the emission spectrum for
each sample, usually at 525 nm. After an initial reading in the absence of
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quencher (F0), quencher was added to the sample in increasing amounts
and the remaining fluorescence (F) determined. Typically, TEMPO was
added in increments of 10–20 mM up to 80 mM, and nitromethane,
thallium acetate, and potassium iodide were added in increments of 5–10
mM up to 40 mM. Ionic strength was adjusted when necessary with KCl.
The final concentrations of thallium acetate and potassium iodide added
were limited by their contribution to the ionic strength of our solutions, and
nitromethane by its solubility in our solutions. All spectra were corrected
for the added volume of the quencher and inner filter effects when neces-
sary. The relative fluorescence change F0/F was then plotted versus the
quencher concentration for each experiment to assess the accessibility of
FHS at Lys-553 of myosin S1 to the various solvent quenchers (Q). The
resulting plots were fit to the Stern-Volmer relationship for dynamic
solvent quenching using a linear least-squares routine in SigmaPlot (v5.0,
SPSS Inc., Chicago, IL).:
F0/F KSVQ 1 (1)
where the slope, KSV, is the Stern-Volmer constant that qualitatively
describes the degree of accessibility of the fluorescent probe (FHS) to the
solvent (Eftink and Ghiron, 1976).
RESULTS
Labeling of myosin S1 with FHS
Skeletal muscle S1 was selectively labeled with FHS on the
myosin heavy chain at a molar ratio of 0.84:1 (FHS/S1) as
determined spectrophotometrically. Limited tryptic diges-
tion of the myosin heavy chain indicated that the 50 kD
subdomain was the sole site of fluorescent modification
(Fig. 1), suggesting that Lys-553 was the predominate site
of incorporation of FHS (Bertrand et al., 1995). Modifica-
tion of Lys-553 resulted in small alterations in the actin-
activated ATPase activity of FHS-S1 (Fig. 2). Unmodified
S1 had a Vmax of 11.8 s
1 and a Km of 19 M, while
FHS-S1 had a Vmax of 6.3 s
1 and a Km of 26 M, after
adjustment for the fraction of unmodified S1 molecules
(0.16). The relatively small decrease in Vmax and lack of a
significant change in the Km value for FHS-S1 relative to
unmodified S1 suggests that FHS-modified S1 is a func-
tional myosin subfragment that can hydrolyze ATP in an
actin-dependent manner, and interact normally with actin.
Furthermore, FHS-S1 also binds as well to actin in a rigor
or ADP-rigor complex in centrifuge pelleting assays as
unmodified S1 (data not shown). The binding of FHS-S1 to
actin during steady-state ATP hydrolysis (Keq  3.44 
0.36  103 M1) was only slightly lower than that of
unmodified S1 (Keq  7.42  0.41  10
3 M1 (Berger et
al., 1989)) as shown in Fig. 6 below.
Solvent quenching of the rigor
acto-FHS-S1 complex
Fluorescence quenching experiments were carried out to
examine the solvent accessibility of FHS at Lys-553 of
skeletal muscle myosin S1 bound to actin in a rigor com-
plex. Binding of actin did not appreciably change the fluo-
rescence emission spectrum of FHS-S1 (data not shown).
The fluorescence from FHS-S1 was effectively quenched by
all four solvent quenchers used (Fig. 3), with TEMPO being
the most efficient quencher used (KSV  22.5  0.6 M
1),
followed by iodide (KSV  11.9  0.3 M
1), nitromethane
(KSV  6.0  0.5 M
1), and thallium (KSV  6.0  0.1
M1). When bound to actin in a rigor complex, FHS-S1 was
quenched almost as effectively with TEMPO (KSV 
20.7  0.8 M1), nitromethane (KSV  5.5  0.2 M
1),
and thallium (KSV  5.3  0.3 M
1) as in the absence of
actin (Fig. 3). However, quenching by iodide was reduced
almost twofold when FHS-S1 was bound to actin in a rigor
complex (KSV  6.8  0.4 M
1) compared to FHS-S1
FIGURE 1 Fluorescent image of a limited tryptic digest of FHS-S1
(1:100 wt/wt ratio of trypsin/S1 at 25°C) run on a 6–12% gradient
SDS-polyacrylamide gel. Lane 1: prior to addition of trypsin (0	). Lanes 2
and 3: at 5	 and 10	 after the addition of trypsin. Lane 4: fluorescent
molecular weight standards (molecular weights (MW) are given at the
right). The 50 kD fragment is selectively labeled by FHS.
FIGURE 2 Actin-activated ATPase activities of unmodified (F) and
FHS-labeled S1 (E). Data were fit assuming Michaelis-Menten kinetics.
For unmodified S1 Vmax 11.8 s
1 and Km 19 M. For FHS-S1 Vmax
6.3 s1 and Km  26 M, after correction for the fraction of unmodified
S1 molecules (0.16).
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alone (Fig. 3). Together, these results suggest that the FHS
probe at Lys-553 is not sterically protected from solvent
access when myosin S1 is bound to actin in a rigor complex,
but that actin may be providing an electrostatic shielding
from the negatively charged iodide quencher. To further test
this hypothesis, the iodide quenching experiments were
repeated at a significantly higher salt concentration (Fig. 4).
In the presence of 150 mM KCl, as expected, iodide was a
less effective quencher of fluorescence from FHS-S1 alone
(KSV 7.5 0.2 M
1). The protection offered from iodide
quenching by actin binding, however, was virtually abol-
ished (KSV  7.6  0.7 M
1), suggesting that the result
observed at the lower salt concentration is indeed an elec-
trostatic effect rather than a steric one.
Solvent quenching of the acto-FHS-S1-MgADP
ternary complex
We also examined whether the structure of the acto-myosin
interface at Lys-553 was altered by the binding of MgADP
to the active site of myosin, which results in the formation
of a strongly bound ternary complex. Addition of MgADP
did not appreciably change the fluorescence emission spec-
trum of the rigor FHS-S1/actin complex (data not shown).
Fluorescence quenching experiments using iodide as a sol-
vent quencher were repeated as above for FHS-S1 and
acto-FHS-S1 in the presence of 2 mM MgADP (Fig. 5). At
low salt, the fluorescence from FHS-S1 was quenched ef-
fectively in the presence of 2 mM MgADP (KSV  12.2 
0.4 M1). Furthermore, as seen with the rigor acto-FHS-S1
complex, the degree of quenching decreased almost twofold
when FHS-S1 was bound to actin in the presence of 2 mM
MgADP (KSV  7.5  0.4 M
1). At higher salt concentra-
tions (150 mM KCl) the results were again similar in the
presence of 2 mM MgADP to those observed above in the
absence of nucleotide. The overall degree of quenching
decreased for FHS-S1 in the absence of actin (KSV  7.4 
0.4 M1), and was almost identical to that of FHS-S1 bound
to actin (KSV  6.9  0.3 M
1). Thus, addition of MgADP
to the rigor acto-S1 complex does not significantly alter the
actin-binding interface of skeletal muscle myosin S1 at
Lys-553.
FIGURE 3 Stern-Volmer plots of 1 M FHS-S1 alone (E) and in the presence of 5 M actin (F) quenched by (A) TEMPO, (B) nitromethane, (C)
thallium acetate, and (D) potassium iodide. KSV, the Stern-Volmer quenching constant, was determined using Eq. 1. Values are given as the mean  SE.
1444 MacLean et al.
Biophysical Journal 78(3) 1441–1448
Solvent quenching during the steady-state
hydrolysis of MgATP
Finally, we examined whether the structure of the acto-
myosin interface at Lys-553 is different in the weakly bound
states than in the strongly bound states. Addition of MgATP
did not appreciably change the fluorescence emission spec-
trum of the rigor FHS-S1/actin complex (data not shown).
Fluorescence quenching experiments using iodide as a sol-
vent quencher were repeated as above with 1 M FHS-S1 in
the presence of 10–80 M actin and 20 mMMgATP at low
ionic strength. The fluorescence from FHS-S1 was just as
effectively quenched by iodide in the presence of 20 mM
MgATP at all actin concentrations tested as in the absence
of actin, despite the fact the fraction of myosin heads bound
to actin increased significantly from
5% at 10 M actin to
20% at 80 M actin (Fig. 6). Thus, the acto-myosin
interface around Lys-553 of myosin is substantially altered
in the weakly bound states during the steady-state hydroly-
sis of MgATP from that of the strongly bound states. These
results suggest that the lower 50 kD subdomain of myosin
containing Lys-553 only interacts with actin in the strongly
bound states and not in the weakly bound states of the
MgATPase cycle.
DISCUSSION
Summary of results
The accessibility of FHS, a fluorescent probe that specifi-
cally labels Lys-553 at the putative actin-binding interface
of skeletal muscle myosin S1, was examined in the presence
of a variety of neutral and charged solvent quenchers for
FHS-S1 alone, complexed to actin in a strongly bound state
(i.e., rigor or ADP-rigor), or complexed to actin in a weakly
bound state (i.e., during steady-state ATP hydrolysis). FHS
was equally accessible to neutral and positively charged
FIGURE 4 Stern-Volmer plots of 1 M FHS-S1 alone (E) and in the
presence of 5 M actin (F) quenched by potassium iodide at (A) 0 mM
KCl and (B) 150 mM KCl. KSV, the Stern-Volmer quenching constant, was
determined using Eq. 1. Values are given as the mean  SE.
FIGURE 5 Stern-Volmer plots of 1 M FHS-S1  2 mM MgADP (E)
and in the presence of 5 M actin  2 mM MgADP (F) quenched by
potassium iodide at (A) 0 mM KCl and (B) 150 mM KCl. KSV, the
Stern-Volmer quenching constant, was determined using Eq. 1. Values are
given as the mean  SE.
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solvent quenchers under all conditions studied, even in a
rigor complex with actin. However, actin protects FHS from
the negatively charged solvent quencher iodide in the
strongly bound (i.e., the rigor and acto-FHS-S1-MgADP
complexes), but not weakly bound (i.e., during steady-state
ATP hydrolysis), states of the MgATPase cycle. Thus, the
lower 50 kD subdomain of myosin containing Lys-553
appears to interact with actin differently in the weakly and
strongly bound states. The protection offered to FHS by
actin in the strongly bound states is abolished with the
addition of relatively high concentrations of salt (150 mM
KCl), suggesting that this effect is electrostatic rather than
steric in nature, and that the helix containing Lys-553 in
myosin binds near a negatively charged region of actin in
the rigor and ADP-rigor complexes.
Fluorescent labeling of FHS-S1
Bertrand et al. (1995) originally reported that the myosin
heavy chain can be extensively (0.9 mol FHS/mol S1) and
specifically labeled by FHS. Furthermore, Lys-553 was the
predominant site of modification by FHS, with only a rel-
atively small amount (
15%) of additional modification at
Lys-640 in the 50/20 kD loop (Bertrand et al., 1995). We
have confirmed this result, demonstrating that only the 50
kD subdomain of myosin is fluorescently labeled by FHS at
almost stoichiometric amounts (84%). While it is likely that
our preparation also has been labeled to a small extent at
Lys-640, the low level of incorporation at this site should
not contribute greatly to our observed signal, of which at
least 85% arises from the FHS-modified Lys-553 residues.
Modification of Lys-553 by FHS does slightly alter the
enzymatic properties of myosin. Bertrand et al. (1995) re-
ported that the K-EDTA ATPase activity of FHS-modified
S1 is unaltered relative to unmodified S1, while the Ca2-
and Mg2-ATPase activities are increased 150–200% over
unmodified S1. Our preparation shows similar effects on the
K-EDTA, Ca2-, and Mg2-ATPase activities of FHS-S1
(data not shown). Our actin-activated ATPase and actin-
binding data are similar to those of Bertrand et al. (1995) as
well, who reported a twofold decrease in Vmax without a
change in Km, and no significant effect on the ability of
FHS-S1 to bind to actin in a normal rigor complex. We also
found no observable difference in the ability of FHS-S1 to
bind to actin in the presence of MgADP, and only a minor
difference in the binding of FHS-S1 to actin during steady-
state ATP hydrolysis (Keq  3.44  0.36  10
3 M1),
compared to that of unmodified S1 (Keq  7.42  0.41 
103 M1 (Berger et al., 1989)).
Role of Lys-553 in actin binding
Three-dimensional reconstructions of cryoelectron micro-
graphs of myosin subfragment 1 (S1) bound to F-actin have
been used to “dock” the atomic structures of S1 and actin
together in a rigor complex (Rayment et al., 1993b; Milli-
gan, 1996; Mendelson and Morris, 1997). The resulting
models postulate that myosin binds to actin in a sequential,
multi-step process, in which myosin first binds to actin in a
weakly bound, rapid equilibrium state, followed by the
formation of a strongly bound, stereospecific complex. Lys-
553 is located in the middle of the second -helix (residues
Asp-547 to His-558) in the helix-loop-helix motif of the
lower 50 kD subdomain of myosin that is thought to be one
of these putative actin-binding regions (Rayment et al.,
1993b). However, it is unclear whether this site in myosin is
involved in binding to actin in the weakly bound state, the
strongly bound state, or both. Bertrand et al. (1995) dem-
onstrated that labeling Lys-553 with FHS could be specif-
ically blocked when myosin was bound to actin in a rigor
complex, suggesting that this residue forms part of the
actin-binding interface. However, it is also possible that
actin induces local conformational changes in myosin that
make Lys-553 less accessible to or less reactive with FHS.
Onishi et al. (1995) demonstrated that mutating two hydro-
phobic amino acids in the same -helix as Lys-553 to more
polar residues (W546S and F547H) results in greatly de-
pressed actin-activated ATPase activities. More recently,
we have demonstrated that the fluorescence emission from
tryptophan 546 in smooth muscle myosin undergoes a sub-
stantial blue-shift upon actin binding in the rigor and ADP-
rigor complexes (Yengo et al., 1998; 1999). Taken together,
these results all support a model in which the -helix
containing Lys-553 plays an active role in binding to actin
in the strongly bound states (i.e., the ADP and rigor states).
Our current results also support such a model, since the FHS
FIGURE 6 Relative Stern-Volmer constant calculated from potassium
iodide quenching plots of 1 M FHS-S1 (E) and fraction of 1 M FHS-S1
bound to actin (F) as a function of actin concentration in the presence of
20 mM MgATP at low ionic strength (0 mM KCl). Stern-Volmer quench-
ing constants were determined at each actin concentration using Eq. 1. The
fraction of FHS-S1 molecules bound to actin at each actin concentration
was determined from a centrifuge pelleting assay as described in Methods.
Values are given as the mean  SE.
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probe at Lys-553 is close enough to actin to be protected
from solvent quenching by potassium iodide in the strongly
bound rigor and ADP-rigor states.
It is possible that the -helix in myosin containing Lys-
553 plays an active role in binding to actin in the weakly
bound states as well (i.e., the ATP and ADP  Pi states). The
weakly bound state is believed to involve a primarily ionic
interaction between the positively charged, flexible surface
loop that links the 50 kD and 20 kD tryptic fragments of the
myosin heavy chain and the negatively charged N-terminus
of actin. Evidence for the interaction of the 50/20 kD
junction in myosin with the N-terminus of actin in the
weakly bound state includes the protection of this loop from
proteolytic cleavage by actin (Mornet et al., 1979), and
alterations in this loop impact the actin-activated ATPase
and actin-binding activities of myosin (Uyeda et al., 1994;
Rovner et al., 1995). However, we find that during steady-
state ATP hydrolysis, when myosin is predominantly in the
weakly bound state, that actin offers virtually no protection
from iodide quenching, even when the actin concentrations
are sufficiently high (80 M) to have a significant fraction
of the FHS-S1 molecules bound to actin (20%). Thus, our
results demonstrate that it is unlikely that the lower 50 kD
subdomain of myosin containing Lys-553 interacts with
actin in the weakly bound states. At the very least, such an
interaction must be substantially different in the weakly and
strongly bound states to account for the differences in the
accessibility of the FHS probe at Lys-553 under the two
different sets of experimental conditions. This is the first
direct evidence for a difference in the way that the lower 50
kD subdomain interacts with actin in the weakly and
strongly bound states. Thus, incorporation of the lower 50
kD subdomain of myosin may be the first step in the
formation of the strongly bound complex between actin and
myosin.
In the strongly bound states, why is the FHS group
covalently bound to Lys-553 only protected from solvent
quenching by actin when iodide is used as the quencher, and
not nitromethane, TEMPO, or thallium? The six-carbon
spacer arm between the reactive succinimidyl and fluores-
cent fluorescein groups in FHS may provide enough dis-
tance and flexibility to keep the bulky fluorophore out of the
actual interface between actin and myosin. This would
explain the lack of an effect by FHS labeling on rigor
binding and the Km for actin-activated ATPase activity.
Furthermore, if the fluorescein group is indeed at the edge
of the actin-binding interface of myosin, the predominantly
negatively charged surface of actin would be expected to
protect FHS from quenching by the negatively charged
iodide ion by electrostatic repulsion. However, the neutral
quenchers nitromethane and TEMPO would not be steri-
cally or electrostatically shielded from FHS by actin, and
thus should effectively quench the fluorescein fluorescence
even in the ADP-rigor and rigor complexes. If electrostatic
shielding is indeed the mechanism by which actin protects
the FHS probe on myosin, it is curious that actin does not
enhance quenching by the positively charged thallium ion.
One possible explanation is that positive charges on myosin
around the FHS-probe repel the thallium ion in both the free
and actin-bound states of myosin, and would also act to
enhance the quenching efficiency of iodide for FHS-S1
alone, particularly at low salt concentrations as observed in
our data.
It is important to note that no difference was observed in
the ability of iodide to quench FHS-S1 in either the ADP-
rigor or rigor complexes, suggesting that the interaction
between the helix containing Lys-553 in myosin and actin is
unaltered by ADP release. Whittaker et al. (1995), using
reconstructions of cryo-EM images, found a small but sta-
tistically significant difference in the acto-myosin interface
of smooth muscle myosin upon ADP release. Thus, rear-
rangements in the acto-myosin interface are likely to occur
elsewhere in myosin and/or in actin. We have recently
demonstrated using intrinsic tryptophan fluorescence that
the myopathy loop (residues Arg-405 to Lys-415 in the
skeletal muscle myosin sequence) in the upper 50 kD sub-
domain of smooth muscle myosin alters its conformation
upon ADP release when complexed with actin, while the
lower 50 kD subdomain containing Lys-553 is unaffected
by ADP release (Yengo et al., 1999).
Future directions
Given the large negative surface potential of actin it is
difficult to speculate which regions of actin the fluorescein
probe may be near in the rigor complex. Fluorescence
resonance energy transfer experiments (FRET) between
FHS at Lys-553 in myosin and donor probes on actin (e.g.,
IAEDANS at Cys-374 or dansyl at Gln-41) may be useful in
properly orienting the actin and myosin molecules with each
other in the rigor complex. FHS-labeled S1 has already been
used as acceptor for determining intermolecular distances
by FRET within the myosin head, using IAEDANS conju-
gated to Cys-177 of the essential light chain as the donor
(Smyczynski and Kasprzak, 1997). Transient kinetic anal-
ysis of the fluorescence emission in the presence of potas-
sium iodide following rapid mixing of FHS-S1 and actin
may also help address questions about the order in which
different subdomains of myosin bind to actin in forming the
strongly bound complex.
The sensitivity of FHS-labeled myosin heads to iodide
quenching as a function of actin binding reported in this
work may be applicable to determining the fraction of
actin-bound cross-bridges in the myofilament lattice, as-
suming that Lys-553 can still be specifically modified in
myosin under these conditions. In the accompanying paper
(Cooper et al., 2000), we demonstrate that myosin can be
specifically labeled at Lys-553 in skeletal muscle myofi-
brils, and the FHS probe retains it sensitivity to iodide
quenching in the relaxed state, but not in the rigor state, at
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low ionic strength. This technique should have direct appli-
cations for the real-time determination of the fraction of
actin-bound cross-bridges within the myofilament lattice
under a variety of mechanical conditions, and help address
critical questions about chemomechanical coupling in mus-
cle contraction.
CONCLUSIONS
We found that actin protects the FHS probe at Lys-553 of
the myosin heavy chain from solvent quenching by potas-
sium iodide in the strongly bound (i.e., the rigor and acto-
FHS-S1-MgADP complexes), but not weakly bound
(i.e., during steady-state ATP hydrolysis), states of the
MgATPase cycle. Thus, it appears that the lower 50 kD
subdomain of myosin containing Lys-553 interacts with
actin differentially in the strongly and weakly bound states.
Such a dynamic structural change at the acto-myosin inter-
face may provide at least part of the mechanism responsible
for the large affinity change between actin and myosin at
this critical transition in the MgATPase cycle.
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